GRAS Notices
-
GRN No. 411
Egg yolk-derived phospholipids
Intended Use: | As an ingredient in term and preterm infant formula at levels up to 2 grams phospholipids per liter of formula, providing a maximum of 0.28% and 0.18% of total fatty acids as arachidonic acid and docosahexaenoic acid, respectively |
---|---|
Basis: | Scientific procedures |
Notifier: |
Laurent PHILIPPIN OVOLIFE |
Notifier Address: |
BNLfood Investments SARL 1, z.a. Salzbaach L 9559 - Wiltz - LUXEMBOURG |
Date of filing: | Jan 4, 2012 |
GRAS Notice (releasable information): | GRN 411 (in PDF) |
Date of closure: | Nov 20, 2012 |
FDA's Letter: | FDA has no questions |
-